Carey Anders, MD, medical director of Duke Brain and Spine Metastases Program, and Andrew Brenner, MD, professor of medicine and breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss what’s new for the treatment for CNS disease in metastatic breast cancer.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: CNS disease updates
Join the global breast cancer community for four days of research spanning experimental biology, etiology, translational science, prevention, diagnosis and treatment, December 8-11 in San Antonio, Texas.
Share: